Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit’s license territories, including the United States and Europe. Ivonescimab was initially approved ...

Google's privacy policy, effective Oct. 16, 2026, lets opt-in Gmail, Drive and Photos data feed personalized ads. Here is ...

Merck KGaA's $1.3 billion cash purchase of Silence Therapeutics — at roughly a 130% premium — caps a near-death turnaround that former CEO ...

Lee Jung-yeon urges Korea to build domestic server ecosystem for AI era Supply chain control and in-house firmware seen as ...

In conclusion, Hand of Anubis Casino UK delivers on its promise of elite wins wrapped in a captivating theme. It is a place where the past meets the present, offering a gaming experience that is both ...

Brewers' institutional knowledge plays key role in World Series run. Also Purdue's new AD faces new era of college sports, ...

Michael Mandel, senior lecturer in business communication at the Eller College of Management at the University of Arizona, has developed a professional reputation platform using AI and vibe coding to ...

Musk says Optimus could drive 80% of Tesla value, alongside the Cybercab targeted under $30,000. See his claims, timelines ...

Shibarium holds only $46,453 on October 23, 2026, while SHIB is valued at $2.998 billion. The figures, the usage and the tax ...